Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Change in Acquisitions & Divestments (2017 - 2025)

Inspire Medical Systems' Change in Acquisitions & Divestments history spans 8 years, with the latest figure at $61.7 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 32.85% year-over-year to $61.7 million; the TTM value through Dec 2025 reached $310.4 million, down 9.93%, while the annual FY2025 figure was $310.4 million, 9.93% down from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $61.7 million at Inspire Medical Systems, down from $75.0 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $149.5 million in Q2 2025 and bottomed at $246000.0 in Q4 2023.
  • The 4-year median for Change in Acquisitions & Divestments is $54.8 million (2024), against an average of $59.1 million.
  • The largest annual shift saw Change in Acquisitions & Divestments crashed 63.56% in 2021 before it skyrocketed 37238.21% in 2024.
  • A 4-year view of Change in Acquisitions & Divestments shows it stood at $31.3 million in 2021, then tumbled by 99.21% to $246000.0 in 2023, then surged by 37238.21% to $91.9 million in 2024, then plummeted by 32.85% to $61.7 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Change in Acquisitions & Divestments are $61.7 million (Q4 2025), $75.0 million (Q3 2025), and $149.5 million (Q2 2025).